Covaxin phase 1 trials: Results of phase 1 trials of Covaxin vaccine were released in a preprint paper “A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine -BBV152”. Preprint paper is a scientific manuscript version which is posted on public server before formal peer review.  The vaccine’s results propose the Covid-19 vaccine ...

Uttar Pradesh government: UP’s chief minister Yogi Adityanath has set a deadline of December 15 to increase state’s vaccine storage capacity to 2.03 lakh litres. On Wednesday, the top state health official said of government’s confidence in expanding the storage capacity from current 80,000 litres to 2.03L litres by the deadline. The DCGI approved Covid-19 ...

SII & Bharat Biotech: India’s hopes of getting Covid-19 vaccines in a matter of days flickered away – India might have to wait just a bit longer to get a country-made vaccine rolled out for the coronavirus. Drug Controller General of India (DCGI) has put the Covid-19 vaccines Covishield and Covaxin on hold for emergency ...

First logistics blueprints: After Pfizer and Serum Institute of India approached India’s medical regulatory body DCGI seeking approval for their vaccine against Covid-19, Hyderabad-based Bharat Biotech too approached the body on Monday for approval of India’s first indigenous Covid-19 vaccine, Covaxin. Citing the progress country is making in manufacturing and procuring Covid-19 vaccine, high level ...

Serum Institute of India:  On Sunday, Serum Institute of India became the first indigenous pharma firm to apply for emergency use of Covishield, the Covid-19 vaccine. SII applied to DCGI (Drugs Controller General of India), India’s drug regulator, seeking authorization for Oxford vaccine’s emergency use in India. This comes a day after DCGI approved emergency ...

Pfizer: On Thursday the pharma giant Pfizer said that it is committed to make the Covid-19 vaccine available to Indian population and is currently working closely with the Indian government to explore opportunities for the procurement and distribution of the Pfizer-BioNTech vaccine against coronavirus.  UK became the first country to approve emergency approval of the ...

Health Minister: On Monday, Union Health Minister Dr. Harsh Vardhan relayed that Indian population can avail Covid-19 vaccine next year by March and April. He also said that the Union Government has planned to make the vaccine available and administered to over 25 crore people in India by July and August next year.  Dr. Harsh ...

Russia’s Sputnik: India has nearly five vaccines for coronavirus under its belt and with the announcement of production of 100 million vaccine doses of Russia’s covid-19 vaccine Sputnik V, India looks at extending its list even more.  It is combine effort of three institution which include the Russian Direct Investmnet Fund, Russia’s sovereign wealth funf ...

Serosurvey: By Friday morning India had crossed 93 lakh mark of Covid-19 cases and added 43,082 new cases in 24 hours. Death tally reached 1,35,715 with 492 new fatalities being added. Recovered patients have reached 87.18 lakh tally.  ICMR (Indian Council of Medical Research) conducted a second national serosurvey that shows over 70% of Indian ...

Mission Covid Suraksha: The Indian government launched a new initiative in the wake of the coronavirus pandemic called ‘Mission Covid Suraksha’ on Wednesday. This initiative will facilitate the development process of nearly five to six vaccine candidates in the country which means the procedure will be accelerated.  Through this project, it will be easier for ...